Controversies in biomedical research
Tuesday 28th March 2006.
The Royal Statistical Society, 12 Errol Street, London, EC1Y 8LX, UK.
Tel: +44(0)20 7638 8998, fax: +44(0)20 7614 3905, http://www.rss.org.uk/
1. What lessons can we learn from the withdrawal of Cox-2 inhibitors?
Ray Bain (Merck): Chronology of Clinically Important Cardiovascular
Event Data in the Rofecoxib (VIOXX) Development Program
Lesley Wise (MHRA): The withdrawal of COX-2 inhibitors: A regulatory
viewpoint
Colin Baigent (CTSU): Do Cox-2 inhibitors and NSAIDs cause
atherothrombosis? A meta-analysis of randomised trials.
11:30 - 12:00 Coffee break
Discussion: Stuart Pocock (LSHTM), Lucien Abenhaim (Paris), general
discussion
13:00 - 14:00 Lunch
2. BiDil and subgrouping
George Ellison (SGHMS): BiDil, subgroup analyses, and the limits of
evidence-based medicine
Discussion
14:50 - 15:10 Tea break
3. Research fraud and its detection
Stephen Evans (LSHTM): Are these data real?
Caroline White (journalist): Suspected research fraud: difficulties of
getting at the truth
Doug Altman (Oxford): Some personal experiences
Damien Downing (Journal of Nutritional and Environmental Medicine):
Editorial Bullying?
General discussion (invited discussants to be confirmed)
17:30 End
|